AI-powered search
Try Polaris, our new AI-powered search!

What rate of facial repigmentation was seen in clinical trials for ruxolitinib in patients with vitiligo?

Featuring Neal Bhatia, MD |

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA

| Published March 03, 2025